Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Lorena Ramos Pérez

Lorena Ramos Pérez

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca
Lorena Ramos Pérez

Lorena Ramos Pérez

Lorena Ramos Pérez

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Funciones Alternativas de la Sex Hormone-Binding Globulin: Mecanismos Moleculares y Papel en Fisiología y Fisiopatología

IP: David Martinez Selva
Collaborators: Maria Teresa Salcedo Allende, Lorena Ramos Pérez, Pablo Gabriel Medina, Pilar Costa Forner
Funding agency: Instituto de Salud Carlos III
Funding: 190000
Reference: PI23/00544
Duration: 01/01/2024 - 31/12/2026

Diabetis i metabolisme

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Rosario Pardo Diaz, Angel Michael Ortiz Zúñiga, Andreea Ciudin Mihai, Fiorella Ximena Palmas Candia, Ana Maria Ortiz de Urbina Olive, Monica Sanchez Bartres, Lorena Ramos Pérez, Marc Rivas Agudo, Diabetis i metabolisme, Anna Casteras Román, Alejandra Planas Vilaseca, Betina Biagetti Biagetti, Judit Amigó Farran, Mercè Abad Martín, Marta Comas Martínez, Hugo Ramos Abellan, Rosa Burgos Peláez, David Sabater Martínez, Olga Simó Servat, Patricia Bogdanov Baruj, Maria Llorian Salvador, Enzamaría Fidilio Meli
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00655
Duration: 01/01/2022 - 30/06/2025

Unraveling the retinal and brain mediators of diabetes-induced neurodegeneration

IP: Rafael Simó Canonge
Collaborators: Santiago Ramon y Cajal Agüeras, Joan Montaner Villalonga, Lorena Ramos Pérez, Hugo Ramos Abellan, Patricia Bogdanov Baruj
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 242000
Reference: PID2019-104225RB-I00
Duration: 01/06/2020 - 31/05/2023

Ministerio de Ciencia

Administración tópica ocular de inhibidores de DPP-4: una nueva estrategia terapéutica para la retinopatía diabética

IP: Cristina Hernández Pascual
Collaborators: J. Bruno Montoro Ronsano, Ana Boixadera Espax, José Raul Herance Camacho, Lorena Ramos Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 119900
Reference: DTS18/00163
Duration: 01/01/2019 - 30/06/2021

Related news

Dra. Andreea Ciudin

A new guideline proposes a change in the pharmacological approach to obesity

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

Dra. Andreea Ciudin, Marta Comas i Juan José Cortés

A new oral drug for obesity shows positive results in an international study

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Equip del grup de Diabetis i Metabolisme del VHIR

Fundaluce supports research into a new therapeutic strategy for retinitis pigmentosa

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

See more

Related professionals

Estela Garcia Gea

Estela Garcia Gea

Research technician
Psychiatry, Mental Health and Addictions
Read more
Erika Ivanna Araya

Erika Ivanna Araya

Postdoctoral researcher
Headache and Neurological Pain
Read more
Santiago Ramon y Cajal Agüeras

Santiago Ramon y Cajal Agüeras

Head of group
Translational Molecular Pathology
Read more
Lorena Viviana Lopez Reyes

Lorena Viviana Lopez Reyes

Research technician
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.